As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. Raymond H. Chen is a senior cardiac surgeon and assistant chief of the Regional Department of Cardiac Surgery for the Southern California Permanente Medical Group. Dr. Chen was 1 of the 4 inaugural members of the Clinician Investigator Program. Before joining the Southern California Permanente Medical Group, Dr. Chen’s research interests included the role of cellular rejection in a cardiac xenotransplantation model and the mechanisms of chronic rejection in human cardiac grafts. He developed ...
Over the years, clinical trials have led to amazing advances in treatment—even cures—for devastating illnesses. William Towner, MD, FACP, FIDSA, regional physician director for clinical trials, describes how trials at Kaiser Permanente contribute to the development of more effective and safer treatments for diseases such as HIV, hepatitis C, cancer, and more. (2:15)
Growing numbers of patients are diagnosed with cancer between the ages of 15 and 39. These younger cancer patients can have complex health needs after their cancer treatment and should receive health care that includes screening for new cancers, addresses potential issues related to their treatment, and emphasizes general preventive care. Researchers at Kaiser Permanente ...
Young cancer survivors were more likely to be on long-term opioid therapy when compared to their counterparts without cancer. But among those on long-term opioid therapy, young cancer survivors were less likely to develop opioid use disorder than their peers without cancer, according to Kaiser Permanente research. The study was published in Cancer in May ...
A novel treatment algorithm developed and implemented within Kaiser Permanente Southern California increased the use of effective medications for people with multiple sclerosis (MS), and reduced treatment disparities for Hispanic and Black patients. “Studies show Hispanic and Black people with MS typically have higher levels of disability than white people, but no studies have addressed ...
Navdeep S. Sangha, MD, is a vascular neurologist and co-assistant chief of Neurology at the Kaiser Permanente Los Angeles Medical Center. He is the director of the Kaiser Permanente Southern California Regional Stroke Program and the Kaiser Permanente Southern California Telestroke Program. He joined Los Angeles Medical Center’s Neurology Department in 2012. As the principal investigator ...
*Final in a series highlighting research nurses during Nurses Week 2025* Michael Fechter, LVN, was an emergency medical technician, working to become a paramedic and firefighter. On one emergency call, a critical care transport nurse suggested something that changed the direction of his career. “She told me that I needed to be where I could ...
The latest IMPACT newsletter, which focuses on research from Kaiser Permanente Southern California, is now available! It features 11 stories on our groundbreaking research, links to over a dozen media stories, and a Q&A with a health economics investigator.
Our behavioral scientists focus on research that has the potential to reduce disease risk by identifying modifiable risk factors and encouraging health-promoting behaviors. Faculty members have expertise in the following areas: adverse childhood experiences, cancer, chronic disease prevention and screening, diet and nutrition, mental health, obesity, physical activity, sedentary behavior, social determinants of health, and weight loss surgery and interventions.
The behavioral research portfolio includes intervention studies as well as qualitative and quantitative studies. The division also supports recruitment and other activities of the Kaiser Permanente Research Bank in Southern California.